Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Amur Minerals ( (GB:CRTX) ).
CRISM Therapeutics announced that all resolutions were passed during their recent Annual General Meeting, demonstrating strong shareholder support. This outcome reinforces the company’s strategic direction in advancing its drug delivery technologies, potentially strengthening its position in the oncology market.
More about Amur Minerals
CRISM Therapeutics Corporation is a UK-based company specializing in innovative drug delivery technologies aimed at enhancing the clinical performance of cancer treatments for solid tumors. Their flagship product, ChemoSeed, is designed for localized delivery of chemotherapy drugs, particularly effective in treating glioblastoma by bypassing the blood-brain barrier.
Average Trading Volume: 54,093
Technical Sentiment Signal: Sell
Current Market Cap: £4.2M
See more data about CRTX stock on TipRanks’ Stock Analysis page.